Sisomicin (3mg/ml)
Ensamycin Eye Drop stops the growth of bacteria and thereby helps to cure the underlying infection. Follow your doctor’s instructions precisely for administering this medicine in the eye. Wait for at least 5 minutes before applying any other eye medication. It should be used regularly at evenly spaced time intervals as prescribed by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medicine too early may lead to the infection returning or worsening.It is a broad-spectrum type of antibiotic effective in killing many types of bacteria. However, it will not work for other types of eye infections (e.g. viral) and therefore, should only be used if prescribed by your doctor. Unnecessary use of any antibiotic can lead to a decrease in its effectiveness in the future.Commonly seen side effects seen with this medicine include temporary eye irritation and burning sensation after administration. Consult your doctor if these side effects persist or if your condition worsens. It may cause some short-term blurring of vision when first used. Therefore, do not drive immediately after administering this medicine. Contact lenses should not be worn while you are using this medicine or while you have an active eye infection.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Ensamycin
3 ml Eye Drop
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.
Ensamycin Eye Drop is an antibiotic. It stops bacterial growth by preventing the synthesis of essential proteins required by bacteria to carry out vital functions. This treats your eye infection.
Related Warnings
No interaction found/established
Information regarding the use of Ensamycin Eye Drop during pregnancy is not available. Please consult your doctor.
Information regarding the use of Ensamycin Eye Drop during breastfeeding is not available. Please consult your doctor.
It is not known whether Ensamycin Eye Drop alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
No interaction found/established
No interaction found/established
Ensamycin Eye Drop is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Ensamycin Eye Drop too early, the symptoms may return or worsen.
No, you should not stop using Ensamycin Eye Drop suddenly without talking to your doctor. This is because your symptoms may worsen and your infection may return. You may experience improvement in your symptoms before the infection is completely cleared. Therefore, it is advised to continue your treatment for the prescribed duration to ensure better results. Stopping the medication too early could allow the spread of the infection and hence prevent complete healing.
If you forget to use Ensamycin Eye Drop, do not worry and continue using Ensamycin Eye Drop as soon as you remember. However, if you are not sure and have any other doubts, please consult your doctor.
Use of Ensamycin Eye Drop should be avoided in patients who are allergic to Ensamycin Eye Drop or any of its components. However, if you are not aware of any allergy or if you are using Ensamycin Eye Drop for the first time, consult your doctor.
Keep Ensamycin Eye Drop in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Keep it away from children and other people to avoid any misuse.
